“Hypertension and PAD are not two separate diseases in a vascular patient — they are one disease seen at different points in the same arterial tree.”
By Dr. Rahul Agarwal | — Consultant Vascular & Endovascular Surgeon, CARE Hospitals, Banjara Hills, Hyderabad
Peripheral artery disease (PAD) — narrowing of the arteries supplying the legs — and hypertension are so frequently found together that clinicians sometimes treat them as coincidental comorbidities. They are not. They share a common causal mechanism, accelerate each other, and require coordinated management.
🔗 The Causal Connection
Hypertension causes PAD through the mechanism of accelerated atherosclerosis. Elevated blood pressure creates mechanical shear stress on arterial walls, damages the endothelium, drives inflammatory plaque formation, and destabilises plaques already present. The aorta and iliac arteries bear the greatest pressure, but the femoral, popliteal, and tibial arteries are where the clinical consequences are most disabling.
Hypertensive patients develop PAD at younger ages, with more widespread disease, and with faster progression than normotensive individuals with otherwise equal risk factor profiles.
📊 How They Interact in Clinical Practice
- Hypertension worsens PAD: Uncontrolled BP accelerates plaque growth in leg arteries. Each 10 mmHg rise in systolic BP is associated with a 25–35% increase in PAD risk in population studies.
- PAD predicts cardiovascular events: Having PAD means you almost certainly have atherosclerosis elsewhere — in the coronary, carotid, and renal arteries. An ABI below 0.9 approximately doubles the 10-year cardiovascular mortality risk, independent of traditional risk factors.
- BP measurement is unreliable in severe PAD: With very low ABI, ankle BP is not reliable for systemic BP monitoring. Brachial BP measurement is preferred in these patients.
- Some antihypertensives affect PAD symptoms: There is a historical concern that beta-blockers worsen claudication by reducing cardiac output and causing peripheral vasospasm. Modern evidence suggests this concern is overstated for cardioselective beta-blockers, but ACE inhibitors and ARBs remain preferred first-line agents in PAD patients with hypertension.
🎯 BP Targets in PAD Patients
- General PAD with hypertension: below 130/80 mmHg
- PAD with diabetes: below 130/80 mmHg
- PAD with CKD: below 130/80 mmHg
- Critical limb ischaemia (rest pain, ulceration): caution — excessive BP lowering can reduce perfusion pressure further in critically ischaemic limbs; target individualised with vascular team
🛡️ The ABI — Connecting Both Diagnoses
The ankle-brachial index (ABI) — the ratio of ankle to brachial systolic pressure — is the key non-invasive test that diagnoses PAD and quantifies its severity. An ABI below 0.9 diagnoses PAD. Every hypertensive patient over 50 with leg symptoms, smoking history, or diabetes should have an ABI performed. It takes 10 minutes in the clinic.
❓ Frequently Asked Questions
I have hypertension and leg pain when I walk. Could this be PAD?
Yes — this combination is highly suspicious for claudication from PAD. Claudication is described as cramping or aching in the calf (most commonly), thigh, or buttock that reliably occurs after a consistent walking distance and resolves within minutes of rest. Seek vascular assessment and ask for an ABI measurement.
My BP medicines make my legs feel heavier. Should I stop them?
Do not stop antihypertensive medications without medical advice. Uncontrolled BP poses far greater risk to your arteries than the mild symptom effect of most BP medicines. Tell your doctor — switching from a non-selective beta-blocker to a cardioselective one, or changing to an ACE inhibitor, often resolves the symptom without sacrificing BP control.
🔑 Key Insights: Hypertension is a primary driver of PAD through accelerated atherosclerosis. Every 10 mmHg rise in systolic BP increases PAD risk by 25–35%. Having PAD doubles 10-year cardiovascular mortality risk. ABI below 0.9 diagnoses PAD. All hypertensive patients over 50 with leg symptoms should have an ABI. ACE inhibitors and ARBs are preferred antihypertensive agents in PAD patients.
📚 Related Reading
- Peripheral Artery Disease (PAD) — Complete Guide
- How High Blood Pressure Destroys Your Arteries
- Aortic Aneurysm: The Silent Killer
👨⚕️ About the Author
Dr. Rahul Agarwal is a Consultant Vascular & Endovascular Surgeon at CARE Hospitals, Banjara Hills, Hyderabad. He specializes in peripheral artery disease, endovascular revascularization, and the management of complex vascular risk in patients with hypertension, diabetes, and CKD.
Medical Disclaimer: This article is intended for general patient education only and does not constitute individualised medical advice. Always consult a qualified medical professional for diagnosis and treatment specific to your condition.